News Daily News New European Device Regulations Are Coming, Could Impact Speed of Approvals Todd Neale May 27, 2016
News Daily News Another CV Outcomes Trial Testing Weight-Loss Drug Contrave Terminated Early Michael O'Riordan April 14, 2016
News Daily News Northwestern Memorial Hospital and Star CV Surgeon Found Not Guilty in Myxo Ring Case Shelley Wood April 08, 2016
News Daily News Good Guys, Bad Guys, or Just Big Money? The Push to Link Patient-Claims Data to Device Outcomes Shelley Wood March 17, 2016
News Daily News FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting Michael O'Riordan March 14, 2016
News Daily News Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion? Michael O'Riordan March 09, 2016
News Daily News Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave Michael O'Riordan March 08, 2016
News Daily News Cardiologist Robert Califf Becomes New Commissioner of the FDA L.A. McKeown February 23, 2016
News Daily News FDA: No Cardiovascular Event Reduction Claim for Ezetimibe Shelley Wood February 16, 2016
News Daily News ROCKET AF Investigators: Problems With Warfarin Monitoring Device Did Not Skew Results Todd Neale February 04, 2016
News Daily News Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures L.A. McKeown December 10, 2015
News Daily News Las Sociedades Publican Recomendaciones para que Operadores y Centros Ofrezcan Intervenciones para el Cierre del AAI L.A. McKeown December 10, 2015
News Daily News Path to Top FDA Post Gets a Bit Rockier for Califf Michael O'Riordan December 09, 2015
News Industry News Amsel Medical Corporation Announces Filing of 2nd 510(k) Pre-Marketing Notification with the US Food and Drug Administration for the Amsel Occluder Device October 27, 2015
News Daily News FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients Yael L. Maxwell July 17, 2015
News Daily News Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years July 07, 2015